Contineum Therapeutics CTNM
NASDAQ CTNM
$8.41 +0.06 (+0.72%)
As of: Oct 22, 2026 · 12:24 PM EDT

Contineum Therapeutics (CTNM) Tax Provisions (2023)

Updated

Contineum Therapeutics (CTNM) reported Tax Provisions of -$161,000 for Q4 2023.

Analysis

Contineum Therapeutics (CTNM) Tax Provisions (2023) Analysis & Trends

For FY2023, Contineum Therapeutics posted Tax Provisions of $450,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,172.40 Bn 1,140.99 Bn 19.71 Bn 2.15 Bn
2 Johnson & Johnson 642.90 Bn 561.42 Bn 17.26 Bn 1.21 Bn
3 AbbVie 502.02 Bn 475.14 Bn 12.70 Bn 662.00 Mn
4 Merck 375.88 Bn 330.26 Bn 12.21 Bn 654.00 Mn
5 Novartis Ag 302.81 Bn 266.80 Bn 11.24 Bn 1.01 Bn
6 Astrazeneca 268.58 Bn 242.27 Bn 12.86 Bn 291.00 Mn
7 Amgen 242.38 Bn 197.78 Bn 7.24 Bn 393.00 Mn
8 Gilead Sciences 193.63 Bn 167.83 Bn 6.22 Bn 242.00 Mn
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn -407.00 Mn
10 Contineum Therapeutics 310.98 Mn -617.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -161,000.00
Sep 30, 2023 -118,000.00
Jun 30, 2023 729,000.00
API Access

Contineum Therapeutics Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=CTNM&period=max&api_key=YOUR_API_KEY